Arrowhead Regional Medical Center: Clinical Trials

19 trials sponsored by Arrowhead Regional Medical Center, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 recruiting, 2 unknown, 1 terminated. 4 Phase 3, 2 Not applicable, 2 Phase 4, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 1, Unknown 1
Not applicable2Recruiting 2
Phase 42Completed 2
Phase 11Recruiting 1
Phase 21Completed 1

Follow Arrowhead Regional Medical Center: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maternal Mindfulness: Depression and Postpartum Pain
Mindfulness - Depression, Unipolar, Pain, Postoperative
Not applicableRecruitingUniversity of Illinois at Urbana-Champaign752025-12-012026-08-06
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
SUN, SUN + Telebridge, ED-ITT - Opioid Use Disorder
Not applicableRecruitingRAND5002024-10-042026-02-19
Oral Calcium Supplementation in Labor
Calcium carbonate - Uterine Contraction, Labor Complication
Phase 2 / Phase 3CompletedArrowhead Regional Medical Center892024-04-302025-07-09
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
Venofer 200 MG Per 10 ML Injection, Ferrous sulfate - Iron Deficiency Anemia of Pregnancy
Phase 3UnknownArrowhead Regional Medical Center9002023-11-212024-04-16
Azithromycin Before Induction
Azithromycin Pill, Placebo - Infections
Phase 1RecruitingArrowhead Regional Medical Center4002023-08-072025-09-12
ABO Blood Group Type Association With COVID-19 Severity
No Intervention - COVID-19, Blood Group Antigen Abnormality
CompletedArrowhead Regional Medical Center5992022-11-102023-05-26
Extremity Trauma At a Level 1 Trauma Center
Packed Red Blood Cell Administration - Trauma Injury, Trauma Blunt
CompletedArrowhead Regional Medical Center200002022-01-012025-01-30
Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection
No Intervention - COVID-19, Diabetes Mellitus
CompletedArrowhead Regional Medical Center5892021-10-142023-06-09
Lactate Monitoring in Traumatic Long Bone Fractures Requiring Emergent Surgical Intervention
Orthopedic Surgery - Lactate Blood Increase, Trauma Blunt
CompletedArrowhead Regional Medical Center1642021-01-012022-11-10
Low Dose Vitamin C in Burns >20% Compared to Previous Studies With High Dose Vitamin C
Vitamin C - Burns, Ascorbic Acid Deficiency
CompletedArrowhead Regional Medical Center542020-12-122022-11-10
Management and Removal of Foreign Bodies in the Emergency Department
No Intervention - Rectal Foreign Body, Rectal Perforation
CompletedArrowhead Regional Medical Center782020-12-082023-06-05
Statins In Intracerbral Hemorrhage
Statins - Intracerebral Hemorrhage
Phase 3RecruitingBeth Israel Deaconess Medical Center14562020-06-102026-04-21
Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients
Acute Kidney Injury
CompletedArrowhead Regional Medical Center2672020-03-012023-07-27
Amphetamine Induced Adult Respiratory Distress Syndrome
Difference in development of Acute Lung Injury in Amphetamine positive and negative patients - Burns, Acute Lung Injury
CompletedArrowhead Regional Medical Center492019-01-012022-11-10
Chronic Hypertension and Pregnancy (CHAP) Project
Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe) - Hypertension
Phase 4CompletedUniversity of Alabama at Birmingham24082015-06-012023-05-17
California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
Tranexamic Acid - Hemorrhagic Shock, Trauma Injury
Phase 3CompletedArrowhead Regional Medical Center2002015-03-012024-07-30
Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
Sofosbuvir and simeprevir - Hepatitis C
UnknownArrowhead Regional Medical Center3402013-11-012015-06-30
Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir
Boceprevir - Hepatitis C Infection
TerminatedArrowhead Regional Medical Center1052011-11-012015-06-30
Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management
Bevacizumab - Pterygium
Phase 4CompletedArrowhead Regional Medical Center312011-04-012012-11-29

Conditions studied

Accidental Injuries (2)  ·  Burns (2)  ·  COVID-19 (2)  ·  Diabetes Mellitus (2)  ·  Hepatitis C (2)  ·  Wounds, Nonpenetrating (2)  ·  Acute Kidney Injury (1)  ·  Acute Lung Injury (1)  ·  Anemia (1)  ·  Ascorbic Acid Deficiency (1)  ·  Cerebral Hemorrhage (1)  ·  Compassion Fatigue (1)  ·  Depression (1)  ·  Depressive Disorder (1)  ·  Dystocia (1)

Interventions

3-hydroxy-3-methylglutaryl-coenzyme A (1)  ·  Ascorbic Acid (1)  ·  Azithromycin (1)  ·  Bevacizumab (1)  ·  Breath Holding (1)  ·  Calcium Carbonate (1)  ·  Ferric Oxide, Saccharated (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Injections (1)  ·  Labetalol (1)  ·  Mindfulness (1)  ·  N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (1)  ·  Nifedipine (1)  ·  Orthopedic Procedures (1)  ·  Simeprevir (1)

Countries

United States (18)

Top investigators

Aldin Malkoc, MD (3)  ·  David T Wong, MD (2)  ·  Michael M Neeki, DO (2)  ·  Alan Tita, MD, PhD (1)  ·  Aldin Malkoc (1)  ·  Alexander Phan, MD (1)  ·  Gary Cutter, PhD (1)  ·  Guillermo Valenzuela, MD (1)  ·  Jeff Szychowski, PhD (1)  ·  Keith Tokuhara, MD (1)  ·  Michael Neeki (1)  ·  Michael Neeki, DO (1)  ·  Zeid Kayali, MD (1)  ·  Zeid Kayali, MD,MBA (1)

Results publications

PMID 20569811, PMID 20951424, PMID 23607594, PMID 24209977, PMID 26971581, PMID 27682034, PMID 28611888, PMID 30089070, PMID 30121943, PMID 30817905, PMID 31413088, PMID 31811820, PMID 31821329, PMID 32793517, PMID 34010223, PMID 34839481, PMID 35113024, PMID 35363951, PMID 35728781, PMID 36107229, PMID 37437694, PMID 37769314, PMID 38429252, PMID 38781591, PMID 38949541, PMID 39075369, PMID 42480078, PMID 8300697

NIH funding

U01HL119242 (1)